Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells

Abstract The current study set out to clarify the role of miR‐424‐5p promoter methylation in epithelial mesenchymal transition (EMT) of hepatocellular carcinoma (HCC) cells. The findings of quantitative real‐time‐polymerase chain reaction and methylation‐sensitive high‐resolution melting assays elic...

Full description

Bibliographic Details
Main Authors: Hong‐Cheng Lv, Yan‐Yan Lv, Gang Wang, Xie‐Hua Zhang, Sheng‐Nan Li, Xiao‐Fen Yue, Wei Lu
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12499
_version_ 1811272632388026368
author Hong‐Cheng Lv
Yan‐Yan Lv
Gang Wang
Xie‐Hua Zhang
Sheng‐Nan Li
Xiao‐Fen Yue
Wei Lu
author_facet Hong‐Cheng Lv
Yan‐Yan Lv
Gang Wang
Xie‐Hua Zhang
Sheng‐Nan Li
Xiao‐Fen Yue
Wei Lu
author_sort Hong‐Cheng Lv
collection DOAJ
description Abstract The current study set out to clarify the role of miR‐424‐5p promoter methylation in epithelial mesenchymal transition (EMT) of hepatocellular carcinoma (HCC) cells. The findings of quantitative real‐time‐polymerase chain reaction and methylation‐sensitive high‐resolution melting assays elicited that miR‐424‐5p was poorly expressed in HCC tissues and cells while highly methylated. Meanwhile, upon demethylation, miR‐424‐5p expression levels were partly recovered in HCC cells. In addition, miR‐424‐5p upregulation reduced cell viability and elevated apoptosis of HCC cells, in parallel with increased N‐cadherin and decreased E‐cadherin levels. Dual‐luciferase reporter assay further validated that miR‐424‐5p bound to the kinesin family member 2A (KIF2A), and miR‐424‐5p overexpression downregulated KIF2A. In addition, KIF2A overexpression reversed the miR‐424‐5p‐driven changes in terms of cell viability, apoptosis and EMT‐related protein levels. Furthermore, xenograft tumors were established via injection of Huh7 cells, followed by miR‐424‐5p overexpression in vivo, which inhabited KIF2A downregulation and attenuated tumor growth along with decreased Ki67 positive expression, diminished N‐cadherin and elevated E‐cadherin levels. Overall, our findings supported the conclusion that miR‐424‐5p promoter methylation reduced miR‐424‐5p expression and upregulated KIF2A, thereby promoting HCC EMT.
first_indexed 2024-04-12T22:43:51Z
format Article
id doaj.art-7bd874837e0e494b9c6d0a12a25ac2b9
institution Directory Open Access Journal
issn 1607-551X
2410-8650
language English
last_indexed 2024-04-12T22:43:51Z
publishDate 2022-04-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-7bd874837e0e494b9c6d0a12a25ac2b92022-12-22T03:13:38ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502022-04-0138433634610.1002/kjm2.12499Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cellsHong‐Cheng Lv0Yan‐Yan Lv1Gang Wang2Xie‐Hua Zhang3Sheng‐Nan Li4Xiao‐Fen Yue5Wei Lu6Department of Hepatobiliary Oncology Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Tianjin ChinaTianjin Second People's Hospital Tianjin ChinaTianjin Union Medical Center Tianjin ChinaDepartment of Hepatobiliary Oncology Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Tianjin ChinaDepartment of Hepatobiliary Oncology Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Tianjin ChinaDepartment of Hepatobiliary Oncology Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Tianjin ChinaDepartment of Hepatobiliary Oncology Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Tianjin ChinaAbstract The current study set out to clarify the role of miR‐424‐5p promoter methylation in epithelial mesenchymal transition (EMT) of hepatocellular carcinoma (HCC) cells. The findings of quantitative real‐time‐polymerase chain reaction and methylation‐sensitive high‐resolution melting assays elicited that miR‐424‐5p was poorly expressed in HCC tissues and cells while highly methylated. Meanwhile, upon demethylation, miR‐424‐5p expression levels were partly recovered in HCC cells. In addition, miR‐424‐5p upregulation reduced cell viability and elevated apoptosis of HCC cells, in parallel with increased N‐cadherin and decreased E‐cadherin levels. Dual‐luciferase reporter assay further validated that miR‐424‐5p bound to the kinesin family member 2A (KIF2A), and miR‐424‐5p overexpression downregulated KIF2A. In addition, KIF2A overexpression reversed the miR‐424‐5p‐driven changes in terms of cell viability, apoptosis and EMT‐related protein levels. Furthermore, xenograft tumors were established via injection of Huh7 cells, followed by miR‐424‐5p overexpression in vivo, which inhabited KIF2A downregulation and attenuated tumor growth along with decreased Ki67 positive expression, diminished N‐cadherin and elevated E‐cadherin levels. Overall, our findings supported the conclusion that miR‐424‐5p promoter methylation reduced miR‐424‐5p expression and upregulated KIF2A, thereby promoting HCC EMT.https://doi.org/10.1002/kjm2.12499epithelial–mesenchymal transitionhepatocellular carcinomamethylationmicroRNA‐424‐5ppromoter region
spellingShingle Hong‐Cheng Lv
Yan‐Yan Lv
Gang Wang
Xie‐Hua Zhang
Sheng‐Nan Li
Xiao‐Fen Yue
Wei Lu
Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
Kaohsiung Journal of Medical Sciences
epithelial–mesenchymal transition
hepatocellular carcinoma
methylation
microRNA‐424‐5p
promoter region
title Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
title_full Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
title_fullStr Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
title_full_unstemmed Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
title_short Mechanism of miR‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
title_sort mechanism of mir 424 5p promoter methylation in promoting epithelial mesenchymal transition of hepatocellular carcinoma cells
topic epithelial–mesenchymal transition
hepatocellular carcinoma
methylation
microRNA‐424‐5p
promoter region
url https://doi.org/10.1002/kjm2.12499
work_keys_str_mv AT hongchenglv mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT yanyanlv mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT gangwang mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT xiehuazhang mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT shengnanli mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT xiaofenyue mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells
AT weilu mechanismofmir4245ppromotermethylationinpromotingepithelialmesenchymaltransitionofhepatocellularcarcinomacells